Skip to content

Open-House-Biologika-Rabattverträge 2025-19 - Adalimumab

open

Techniker Krankenkasse

Read the notice at vergabe-de ↗

Value
unstated
Published
17 Nov 2026
Deadline
31 Dec 2026, 22:58 GMT · 40d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600

Description

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Adalimumab im Rahmen eines Open-House-Verfahrens.

Key facts

Reference
OB-2025-19
Procedure
open
Lots
1
Contact
DZEM@tk.de
+49 4069094-040
Bids opened
31 Dec 2026, 22:59 GMT
Regime
publicSector
  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • Calendar export — the deadline as a calendar file
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
vergabe-de
Notice id
dce5ee6d-bd50-4aa2-9ac6-c73316e1c3fd
OCID
ocds-mnwr74-30a7d19c-5428-4233-9885-fbd4694eb3f5
First seen
22 Nov 2026
Last updated
22 Nov 2026

Licence CC0 1.0 public domain dedication ↗

Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.

View at source ↗GET /api/v1/tenders/9c4cedce-0362-4ea8-9ce2-5fbaefe8ef3c

The source notice is authoritative — verify deadlines and documents there before bidding.